Global Targeted Protein Degradation Drug Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Protein Degradation Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PROTAC
1.2.3 Molecular Glue
1.3 Market by Application
1.3.1 Global Targeted Protein Degradation Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Protein Degradation Drug Market Perspective (2020-2031)
2.2 Global Targeted Protein Degradation Drug Growth Trends by Region
2.2.1 Global Targeted Protein Degradation Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Protein Degradation Drug Historic Market Size by Region (2020-2025)
2.2.3 Targeted Protein Degradation Drug Forecasted Market Size by Region (2026-2031)
2.3 Targeted Protein Degradation Drug Market Dynamics
2.3.1 Targeted Protein Degradation Drug Industry Trends
2.3.2 Targeted Protein Degradation Drug Market Drivers
2.3.3 Targeted Protein Degradation Drug Market Challenges
2.3.4 Targeted Protein Degradation Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Protein Degradation Drug Players by Revenue
3.1.1 Global Top Targeted Protein Degradation Drug Players by Revenue (2020-2025)
3.1.2 Global Targeted Protein Degradation Drug Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Protein Degradation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Protein Degradation Drug Revenue
3.4 Global Targeted Protein Degradation Drug Market Concentration Ratio
3.4.1 Global Targeted Protein Degradation Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Drug Revenue in 2024
3.5 Global Key Players of Targeted Protein Degradation Drug Head office and Area Served
3.6 Global Key Players of Targeted Protein Degradation Drug, Product and Application
3.7 Global Key Players of Targeted Protein Degradation Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Protein Degradation Drug Breakdown Data by Type
4.1 Global Targeted Protein Degradation Drug Historic Market Size by Type (2020-2025)
4.2 Global Targeted Protein Degradation Drug Forecasted Market Size by Type (2026-2031)
5 Targeted Protein Degradation Drug Breakdown Data by Application
5.1 Global Targeted Protein Degradation Drug Historic Market Size by Application (2020-2025)
5.2 Global Targeted Protein Degradation Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Protein Degradation Drug Market Size (2020-2031)
6.2 North America Targeted Protein Degradation Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Protein Degradation Drug Market Size by Country (2020-2025)
6.4 North America Targeted Protein Degradation Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Protein Degradation Drug Market Size (2020-2031)
7.2 Europe Targeted Protein Degradation Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Protein Degradation Drug Market Size by Country (2020-2025)
7.4 Europe Targeted Protein Degradation Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Drug Market Size (2020-2031)
8.2 Asia-Pacific Targeted Protein Degradation Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Protein Degradation Drug Market Size (2020-2031)
9.2 Latin America Targeted Protein Degradation Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Protein Degradation Drug Market Size by Country (2020-2025)
9.4 Latin America Targeted Protein Degradation Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Drug Market Size (2020-2031)
10.2 Middle East & Africa Targeted Protein Degradation Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Details
11.1.2 Arvinas Business Overview
11.1.3 Arvinas Targeted Protein Degradation Drug Introduction
11.1.4 Arvinas Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.1.5 Arvinas Recent Development
11.2 Kangpu Biopharmaceuticals
11.2.1 Kangpu Biopharmaceuticals Company Details
11.2.2 Kangpu Biopharmaceuticals Business Overview
11.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Introduction
11.2.4 Kangpu Biopharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.2.5 Kangpu Biopharmaceuticals Recent Development
11.3 Ranok Therapeutics
11.3.1 Ranok Therapeutics Company Details
11.3.2 Ranok Therapeutics Business Overview
11.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Introduction
11.3.4 Ranok Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.3.5 Ranok Therapeutics Recent Development
11.4 Accutar Biotechnology
11.4.1 Accutar Biotechnology Company Details
11.4.2 Accutar Biotechnology Business Overview
11.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Introduction
11.4.4 Accutar Biotechnology Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.4.5 Accutar Biotechnology Recent Development
11.5 BeiGene Ltd.
11.5.1 BeiGene Ltd. Company Details
11.5.2 BeiGene Ltd. Business Overview
11.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Introduction
11.5.4 BeiGene Ltd. Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.5.5 BeiGene Ltd. Recent Development
11.6 Hinova Pharmaceuticals
11.6.1 Hinova Pharmaceuticals Company Details
11.6.2 Hinova Pharmaceuticals Business Overview
11.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Introduction
11.6.4 Hinova Pharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.6.5 Hinova Pharmaceuticals Recent Development
11.7 Haisco Pharmaceutical
11.7.1 Haisco Pharmaceutical Company Details
11.7.2 Haisco Pharmaceutical Business Overview
11.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Introduction
11.7.4 Haisco Pharmaceutical Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.7.5 Haisco Pharmaceutical Recent Development
11.8 Nurix
11.8.1 Nurix Company Details
11.8.2 Nurix Business Overview
11.8.3 Nurix Targeted Protein Degradation Drug Introduction
11.8.4 Nurix Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.8.5 Nurix Recent Development
11.9 Kymera Therapeutics
11.9.1 Kymera Therapeutics Company Details
11.9.2 Kymera Therapeutics Business Overview
11.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Introduction
11.9.4 Kymera Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.9.5 Kymera Therapeutics Recent Development
11.10 C4 Therapeutics
11.10.1 C4 Therapeutics Company Details
11.10.2 C4 Therapeutics Business Overview
11.10.3 C4 Therapeutics Targeted Protein Degradation Drug Introduction
11.10.4 C4 Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.10.5 C4 Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Targeted Protein Degradation Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PROTAC
Table 3. Key Players of Molecular Glue
Table 4. Global Targeted Protein Degradation Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Targeted Protein Degradation Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Targeted Protein Degradation Drug Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Targeted Protein Degradation Drug Market Share by Region (2020-2025)
Table 8. Global Targeted Protein Degradation Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Targeted Protein Degradation Drug Market Share by Region (2026-2031)
Table 10. Targeted Protein Degradation Drug Market Trends
Table 11. Targeted Protein Degradation Drug Market Drivers
Table 12. Targeted Protein Degradation Drug Market Challenges
Table 13. Targeted Protein Degradation Drug Market Restraints
Table 14. Global Targeted Protein Degradation Drug Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Targeted Protein Degradation Drug Market Share by Players (2020-2025)
Table 16. Global Top Targeted Protein Degradation Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation Drug as of 2024)
Table 17. Ranking of Global Top Targeted Protein Degradation Drug Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Targeted Protein Degradation Drug Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Targeted Protein Degradation Drug, Headquarters and Area Served
Table 20. Global Key Players of Targeted Protein Degradation Drug, Product and Application
Table 21. Global Key Players of Targeted Protein Degradation Drug, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Protein Degradation Drug Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Targeted Protein Degradation Drug Revenue Market Share by Type (2020-2025)
Table 25. Global Targeted Protein Degradation Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Targeted Protein Degradation Drug Revenue Market Share by Type (2026-2031)
Table 27. Global Targeted Protein Degradation Drug Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Targeted Protein Degradation Drug Revenue Market Share by Application (2020-2025)
Table 29. Global Targeted Protein Degradation Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Targeted Protein Degradation Drug Revenue Market Share by Application (2026-2031)
Table 31. North America Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Targeted Protein Degradation Drug Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Targeted Protein Degradation Drug Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Targeted Protein Degradation Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Targeted Protein Degradation Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Targeted Protein Degradation Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Targeted Protein Degradation Drug Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Targeted Protein Degradation Drug Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Arvinas Company Details
Table 47. Arvinas Business Overview
Table 48. Arvinas Targeted Protein Degradation Drug Product
Table 49. Arvinas Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 50. Arvinas Recent Development
Table 51. Kangpu Biopharmaceuticals Company Details
Table 52. Kangpu Biopharmaceuticals Business Overview
Table 53. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product
Table 54. Kangpu Biopharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 55. Kangpu Biopharmaceuticals Recent Development
Table 56. Ranok Therapeutics Company Details
Table 57. Ranok Therapeutics Business Overview
Table 58. Ranok Therapeutics Targeted Protein Degradation Drug Product
Table 59. Ranok Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 60. Ranok Therapeutics Recent Development
Table 61. Accutar Biotechnology Company Details
Table 62. Accutar Biotechnology Business Overview
Table 63. Accutar Biotechnology Targeted Protein Degradation Drug Product
Table 64. Accutar Biotechnology Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 65. Accutar Biotechnology Recent Development
Table 66. BeiGene Ltd. Company Details
Table 67. BeiGene Ltd. Business Overview
Table 68. BeiGene Ltd. Targeted Protein Degradation Drug Product
Table 69. BeiGene Ltd. Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 70. BeiGene Ltd. Recent Development
Table 71. Hinova Pharmaceuticals Company Details
Table 72. Hinova Pharmaceuticals Business Overview
Table 73. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product
Table 74. Hinova Pharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 75. Hinova Pharmaceuticals Recent Development
Table 76. Haisco Pharmaceutical Company Details
Table 77. Haisco Pharmaceutical Business Overview
Table 78. Haisco Pharmaceutical Targeted Protein Degradation Drug Product
Table 79. Haisco Pharmaceutical Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 80. Haisco Pharmaceutical Recent Development
Table 81. Nurix Company Details
Table 82. Nurix Business Overview
Table 83. Nurix Targeted Protein Degradation Drug Product
Table 84. Nurix Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 85. Nurix Recent Development
Table 86. Kymera Therapeutics Company Details
Table 87. Kymera Therapeutics Business Overview
Table 88. Kymera Therapeutics Targeted Protein Degradation Drug Product
Table 89. Kymera Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 90. Kymera Therapeutics Recent Development
Table 91. C4 Therapeutics Company Details
Table 92. C4 Therapeutics Business Overview
Table 93. C4 Therapeutics Targeted Protein Degradation Drug Product
Table 94. C4 Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
Table 95. C4 Therapeutics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report


List of Figures
Figure 1. Targeted Protein Degradation Drug Picture
Figure 2. Global Targeted Protein Degradation Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Protein Degradation Drug Market Share by Type: 2024 VS 2031
Figure 4. PROTAC Features
Figure 5. Molecular Glue Features
Figure 6. Global Targeted Protein Degradation Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Targeted Protein Degradation Drug Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Autoimmune Diseases Case Studies
Figure 10. Other Case Studies
Figure 11. Targeted Protein Degradation Drug Report Years Considered
Figure 12. Global Targeted Protein Degradation Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Targeted Protein Degradation Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Targeted Protein Degradation Drug Market Share by Region: 2024 VS 2031
Figure 15. Global Targeted Protein Degradation Drug Market Share by Players in 2024
Figure 16. Global Top Targeted Protein Degradation Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation Drug as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Targeted Protein Degradation Drug Revenue in 2024
Figure 18. North America Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Targeted Protein Degradation Drug Market Share by Country (2020-2031)
Figure 20. United States Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Targeted Protein Degradation Drug Market Share by Country (2020-2031)
Figure 24. Germany Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Targeted Protein Degradation Drug Market Share by Region (2020-2031)
Figure 32. China Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Targeted Protein Degradation Drug Market Share by Country (2020-2031)
Figure 40. Mexico Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Targeted Protein Degradation Drug Market Share by Country (2020-2031)
Figure 44. Turkey Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Arvinas Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 48. Kangpu Biopharmaceuticals Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 49. Ranok Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 50. Accutar Biotechnology Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 51. BeiGene Ltd. Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 52. Hinova Pharmaceuticals Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 53. Haisco Pharmaceutical Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 54. Nurix Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 55. Kymera Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 56. C4 Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit